Skip to main content
Fig. 4 | BMC Nephrology

Fig. 4

From: Warfarin use and stroke, bleeding and mortality risk in patients with end stage renal disease and atrial fibrillation: a systematic review and meta-analysis

Fig. 4

a Sensitivity meta-analysis: stroke outcome by warfarin use, excluding studies with prevalent warfarin users. b Sensitivity meta-analysis: bleeding outcome by warfarin use, excluding studies with prevalent warfarin users. c Sensitivity meta-analysis: mortality by warfarin use, excluding studies with prevalent warfarin users

Back to article page
\